MedTrace Logo

Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)

NCT02407496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-12-10

No results posted yet for this study

Summary

The purpose of this study is develop a new assessment tool for Attention Deficit-Hyperactivity Disorder (ADHD) and to then test its validity (i.e. ability to discriminate between individuals with ADHD and healthy controls).

Conditions

  • Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

OTHER

Behavioral assessment and NAT EEG tests

Individuals in both groups are asked to perform standard behavioral tests and an electroencephalography (EEG) test.

Sponsors & Collaborators

Principal Investigators

  • Gregory V Simpson, Ph.D. · Think Now, Inc.

  • Mark S Cohen, Ph.D. · University of California, Los Angeles

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-07-31
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02407496 on ClinicalTrials.gov